Mediphase Venture Partners logo

Mediphase Venture Partners

North America, Massachusetts, United States, Newton

Description

Mediphase Venture Partners is a Massachusetts-based venture capital firm focused on healthcare and life sciences companies.

Investor Profile

Mediphase Venture Partners has backed more than 20 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 15% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Series B (25%)
  • Series C (20%)
  • Series D (15%)
  • Series A (15%)
  • Series E (10%)
  • Series Unknown (10%)
  • Private Equity (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Oncology
  • Pharmaceutical
  • Electronics
  • Mhealth
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mediphase Venture Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Seaflower Ventures
North America, Massachusetts, United States, Waltham
Co-Investments: 4
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 6
Sprout Group
North America, New York, United States, New York
Co-Investments: 5
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 5
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 5
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 4
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 5
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 5

What are some of recent deals done by Mediphase Venture Partners?

Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series CAug 14, 2012
Amount Raised: $80,000,000
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Private EquityJul 1, 2012
Amount Raised: $62,400,000
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series BAug 8, 2011
Amount Raised: $70,129,747
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series BSep 13, 2010
Amount Raised: $70,000,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series CJun 1, 2010
Amount Raised: $45,000,000
ImpactRx

Mount Laurel, New Jersey, United States

ImpactRx operates as a promotion research organization for the pharmaceutical industry.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series EJan 11, 2010
Amount Raised: $1,200,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series BSep 22, 2009
Amount Raised: $25,000,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series AAug 7, 2008
Amount Raised: $15,000,000
Wellpartner

Portland, Oregon, United States

Wellpartner is a provider of pharmacy distribution solutions for health plans, Medicaid programs, and safety net organizations.

Health CareMedicalPharmaceutical
Series DAug 5, 2008
Amount Raised: $16,100,000
Concert Pharmaceuticals

Lexington, Massachusetts, United States

Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.

BiotechnologyHealth CareMedicalPharmaceutical
Series CApr 30, 2008
Amount Raised: $37,000,000

Find More Investors Like Mediphase Venture Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Mediphase Venture Partners | Pipeseed